MAPT and Alzheimer disease: Likewise, we retrieved characteristic AD phenotypical symptoms (Ghiso and Frangione, 2002; Bennett et al., 2013) such as memory impairment (enriched in both Aβ and tau signatures) and amyloidosis (Aβ).